Login Register Cart 0
Generic placeholder image

Current Chinese Chemistry

Editor-in-Chief

ISSN (Print): 2666-0016
ISSN (Online): 2666-0008

Back
Journal Home About Journal Editorial Board Current Issue Volumes/Issues
Subscribe
Short Communication

Synthesis, Characterization, Textile Dyeing Study and Antimicrobial Activity of 3-(1H-benzo[d]imidazol-2-yl)-2-chloroquinoline

Author(s): Minaxi S. Maru*, Varinder Kaur, Jagriti Behal and Samriti Vaid

Volume 2, Issue 3, 2022

Published on: 22 September, 2022

Article ID: e190822207698 Pages: 5

DOI: 10.2174/2666001602666220819104427

Price: $65

Abstract

Background: Benzimidazoles are important heterocyclic compounds having significant attention in the pharmacological industry due to their various biological and dying properties.

Objective: 3-(1H-benzo[d]imidazol-2-yl)-2-chloroquinoline, a heterocyclic dye (1), was prepared using o-phenylenediamine and 2-chloroquinoline-3-carbaldehyde in the presence of ceric ammonium nitrate catalyst and hydrogen peroxide under reflux condition, which was subjected to mordant and disperse dyeing study and antimicrobial activity to develop antimicrobial textile garment products.

Methods: Elemental analysis, NMR, FT-IR, Mass and UV-visible spectroscopic techniques were used to characterize dye (1). Polyester, wool and silk textile fabrics were selected for the evaluation of dyeing assessment of dispersed heterocyclic dye. The in vitro antimicrobial screening was done against Mycobacterium tuberculosis H37Rv, Streptococcus pyogenes, Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, Candida albicans, Aspergillus niger and Aspergillus clavatus strains using standard drugs as reference.

Results: The deep brown to green shades were observed for dye (1), particularly on polyester samples and showed excellent wash fastness and light fastness properties. Dye (1) was active against Staphylococcus aureus showing 100 μgmL-1 MIC with 16.5 mm ZOI better than the reference drug ampicillin. It was more active against Candida albicans with 12.5, μgmL-1 MIC with 33 mm ZOI in compared to nystatin reference drug during antifungal screening. In primary screening, the MIC value for antimycobacterial activity was <12.5 μgmL-1.

Conclusion: The characteristics values of spectroscopic data support the chemical structure of dye (1). It may become the potent applicant for the production of antimicrobial textile garment products like socks, stockings, caps, etc. due to its fastness, lightning and antimicrobial activity results.

Keywords: Antimicrobial activity, benzimidazole, dyeing property, fastness properties, mordant textile dyeing, fluorescent.

Graphical Abstract

[1]
John, B.W. The chemistry of the benzimidazoles. Chem. Rev., 1951, 48(3), 397-541.
[http://dx.doi.org/10.1021/cr60151a002]
[2]
Guzel, B.; Akgerman, A. Mordant dyeing of wool by supercritical processing. J. Supercrit. Fluids, 2000, 18(3), 247-252.
[http://dx.doi.org/10.1016/S0896-8446(00)00065-6]
[3]
Manian, A.P.; Paul, R.; Bechtold, T. Metal mordanting in dyeing with natural colourants. Color. Technol., 2016, 132(2), 107-113.
[http://dx.doi.org/10.1111/cote.12199]
[4]
Torres-Gómez, H.; Hernández-Núñez, E.; León-Rivera, I.; Guerrero-Alvarez, J.; Cedillo-Rivera, R.; Moo-Puc, R.; Argotte-Ramos, R.; Rodríguez-Gutiérrez, M.C.; Chan-Bacab, M.J.; Navarrete-Vázquez, G. Design, synthesis and in vitro antiprotozoal activity of benzimidazole-pentamidine hybrids. Bioorg. Med. Chem. Lett., 2008, 18(11), 3147-3151.
[http://dx.doi.org/10.1016/j.bmcl.2008.05.009] [PMID: 18486471]
[5]
Mader, M.; de Dios, A.; Shih, C.; Bonjouklian, R.; Li, T.; White, W.; López de Uralde, B.; Sánchez-Martinez, C.; del Prado, M.; Jaramillo, C.; de Diego, E.; Martín Cabrejas, L.M.; Dominguez, C.; Montero, C.; Shepherd, T.; Dally, R.; Toth, J.E.; Chatterjee, A.; Pleite, S.; Blanco-Urgoiti, J.; Perez, L.; Barberis, M.; Lorite, M.J.; Jambrina, E.; Nevill, C.R., Jr; Lee, P.A.; Schultz, R.C.; Wolos, J.A.; Li, L.C.; Campbell, R.M.; Anderson, B.D. Imidazolyl benzimidazoles and imidazo[4,5-b]pyridines as potent p38α MAP kinase inhibitors with excellent in vivo antiinflammatory properties. Bioorg. Med. Chem. Lett., 2008, 18(1), 179-183.
[http://dx.doi.org/10.1016/j.bmcl.2007.10.106] [PMID: 18039577]
[6]
Komazin, G.; Ptak, R.G.; Emmer, B.T.; Townsend, L.B.; Drach, J.C. Resistance of human cytomegalovirus to D- and L-ribosyl benzimidazoles as a tool to identify potential targets for antiviral drugs. Nucleosides Nucleotides Nucleic Acids, 2003, 22(5-8), 1725-1727.
[http://dx.doi.org/10.1081/NCN-120023123] [PMID: 14565505]
[7]
Rao, A.; Chimirri, A.; De Clercq, E.; Monforte, A.M.; Monforte, P.; Pannecouque, C.; Zappalà, M. Synthesis and anti-hIV activity of 1-(2,6-difluorophenyl)-1H,3H-thiazolo[3,4-a]benzimidazole structurally-related 1,2-substituted benzimidazoles. Farmaco, 2002, 57(10), 819-823.
[http://dx.doi.org/10.1016/S0014-827X(02)01300-9] [PMID: 12420877]
[8]
a) Sondhi, S.M.; Rani, R.; Singh, J.; Roy, P.; Agrawal, S.K.; Saxena, A.K. Solvent free synthesis, anti-inflammatory and anticancer activity evaluation of tricyclic and tetracyclic benzimidazole derivatives. Bioorg. Med. Chem. Lett., 2010, 20(7), 2306-2310.
[http://dx.doi.org/10.1016/j.bmcl.2010.01.147] [PMID: 20188544];
b) Refaat, H.M. Synthesis and anticancer activity of some novel 2-substituted benzimidazole derivatives. Eur. J. Med. Chem., 2010, 45(7), 2949-2956.
[http://dx.doi.org/10.1016/j.ejmech.2010.03.022] [PMID: 20399544];
c) Shaharyar, M.; Abdullah, M.M.; Bakht, M.A.; Majeed, J. Pyrazoline bearing benzimidazoles: Search for anticancer agent. Eur. J. Med. Chem., 2010, 45(1), 114-119.
[http://dx.doi.org/10.1016/j.ejmech.2009.09.032] [PMID: 19883957];
d) Gellis, A.; Kovacic, H.; Boufatah, N.; Vanelle, P. Synthesis and cytotoxicity evaluation of some benzimidazole-4,7-diones as bioreductive anticancer agents. Eur. J. Med. Chem., 2008, 43(9), 1858-1864.
[http://dx.doi.org/10.1016/j.ejmech.2007.11.020] [PMID: 18222567];
e) Thimmegowda, N.R.; Nanjunda Swamy, S.; Kumar, C.S.A.; Kumar, Y.C.S.; Chandrappa, S.; Yip, G.W.; Rangappa, K.S. Synthesis, characterization and evaluation of benzimidazole derivative and its precursors as inhibitors of MDA-MB-231 human breast cancer cell proliferation. Bioorg. Med. Chem. Lett., 2008, 18(1), 432-435.
[http://dx.doi.org/10.1016/j.bmcl.2007.08.078] [PMID: 17981032];
f) Demirayak, S.; Abu Mohsen, U.; KuCağri Karaburunmar, A. ynthesis and anticancer and anti-HIV testing of some pyrazino[1,2- a]benzimidazole derivatives. Eur. J. Med. Chem., 2002, 37(3), 255-260.
[http://dx.doi.org/10.1016/S0223-5234(01)01313-7] [PMID: 11900869]
[9]
Patil, A.; Ganguly, S.; Surana, S. A systematic review of benzimidazole derivatives as an antiulcer agent. Rasayan J. Chem., 2008, 1, 447-460.
[10]
Köhler, P. The biochemical basis of anthelmintic action and resistance. Int. J. Parasitol., 2001, 31(4), 336-345.
[http://dx.doi.org/10.1016/S0020-7519(01)00131-X] [PMID: 11400692]
[11]
Evans, B.E.; Rittle, K.E.; Bock, M.G.; DiPardo, R.M.; Freidinger, R.M.; Whitter, W.L.; Lundell, G.F.; Veber, D.F.; Anderson, P.S.; Chang, R.S.L.; Lotti, V.J.; Cerino, D.J.; Chen, T.B.; Kling, P.J.; Kunkel, K.A.; Springer, J.P.; Hirshfield, J. Methods for drug discovery: Development of potent, selective, orally effective cholecystokinin antagonists. J. Med. Chem., 1988, 31(12), 2235-2246.
[http://dx.doi.org/10.1021/jm00120a002] [PMID: 2848124]
[12]
Husain, A.; Varshney, M.M.; Rashid, M.; Mishra, R.; Akhter, A. Benzimidazole: A valuable insight into the recent advances and biological activities. J. Pharm. Res., 2011, 4(2), 413-419.
[13]
Wright, J.B. The chemistry of benzimidazoles. Chem. Rev., 1951, 48(3), 395-541.
[14]
Lawal, A.S.; Nnadiwa, C. Evaluation of wash and light fastness of some selected printed fabrics. ISOR-JPTE, 2014, 1, 01-04.
[15]
Panda, H. Modern Technology of Textile Dyes & Pigments, NIIR Project Consultancy Services, 2nd Edition, Dehli, India, 2003.
[16]
Fadda, A.A.; Etman, H.A.; Amer, F.A.; Barghout, M.; Mohamed, Kh.S. Azo disperse dyes for synthetic fibres. I: 2-Methyl- and 2-phenylquinazolone derivatives. J. Chem. Technol. Biotechnol., 1995, 62, 165-169.
[http://dx.doi.org/10.1002/jctb.280620209]
[17]
Nawrocka, W.; Sztuba, B.; Kowalska, M.W.; Liszkiewicz, H.; Wietrzyk, J.; Nasulewicz, A.; Pełczyńska, M.; Opolski, A. Synthesis and antiproliferative activity in vitro of 2-aminobenzimidazole derivatives. Farmaco, 2004, 59(2), 83-91.
[http://dx.doi.org/10.1016/j.farmac.2003.12.001] [PMID: 14871499]
[18]
Hofmann, K. Imidazole and its derivatives; Wiley Interscience Publishers: New York, 1953.
[19]
a) Mohan, S.; Sundaraganesan, N.; Mink, J. FTIR and raman studies on benzimidazole. Spectrochim. Acta A, 1991, 47(8), 1111-1115.
[http://dx.doi.org/10.1016/0584-8539(91)80042-H];
b) Sundaraganesan, N.; Ilakiamani, S.; Subramani, P.; Joshua, B.D. Comparison of experimental and ab initio HF and DFT vibrational spectra of benzimidazole. Spectrochim. Acta A Mol. Biomol. Spectrosc., 2007, 67(3-4), 628-635.
[http://dx.doi.org/10.1016/j.saa.2006.08.020] [PMID: 16979935]
[20]
Özçelik, S.; Gül, A. Boronic ester of a phthalocyanine precursor with a salicylaldimino moiety. J. Organomet. Chem., 2012, 699, 87-91.
[http://dx.doi.org/10.1016/j.jorganchem.2011.11.016]

Rights & Permissions Print Cite
Article Metrics
1
© 2024 Bentham Science Publishers | Privacy Policy